Literature DB >> 24983218

Update in lung transplantation 2013.

Jamie L Todd1, Jason D Christie, Scott M Palmer.   

Abstract

Research in pulmonary transplantation is actively evolving in quality and scope to meet the challenges of a growing population of lung allograft recipients. In 2013, research groups leveraged large publicly available datasets in addition to multicenter research networks and single-center studies to make significant contributions to our knowledge and clinical care in the areas of donor use, clinical transplant outcomes, mechanisms of rejection, infectious complications, and chronic allograft dysfunction.

Entities:  

Keywords:  bronchiolitis obliterans syndrome; donor; infection; lung transplantation; rejection

Mesh：

Year:  2014        PMID： 24983218      PMCID： PMC4226029          DOI： 10.1164/rccm.201402-0384UP

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


  50 in total

1.  Development and validation of a lung transplant-specific disability questionnaire.

Authors:  Jonathan Paul Singer; Paul David Blanc; Y Monica Dean; Steven Hays; Lorriana Leard; Jasleen Kukreja; Jeffrey Golden; Patricia P Katz
Journal:  Thorax       Date:  2013-12-19       Impact factor: 9.139

2.  Survival effect of lung transplantation among patients with cystic fibrosis.

Authors:  T G Liou; F R Adler; B C Cahill; S C FitzSimmons; D Huang; J R Hibbs; B C Marshall
Journal:  JAMA       Date:  2001-12-05       Impact factor: 56.272

3.  Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction.

Authors:  Masaaki Sato; Thomas K Waddell; Ute Wagnetz; Heidi C Roberts; David M Hwang; Ayesha Haroon; Dirk Wagnetz; Cecilia Chaparro; Lianne G Singer; Michael A Hutcheon; Shaf Keshavjee
Journal:  J Heart Lung Transplant       Date:  2011-03-17       Impact factor: 10.247

4.  Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome.

Authors:  Shiraz A Daud; Roger D Yusen; Bryan F Meyers; Murali M Chakinala; Michael J Walter; Aviva A Aloush; G Alexander Patterson; Elbert P Trulock; Ramsey R Hachem
Journal:  Am J Respir Crit Care Med       Date:  2006-12-07       Impact factor: 21.405

5.  Development of the new lung allocation system in the United States.

Authors:  T M Egan; S Murray; R T Bustami; T H Shearon; K P McCullough; L B Edwards; M A Coke; E R Garrity; S C Sweet; D A Heiney; F L Grover
Journal:  Am J Transplant       Date:  2006       Impact factor: 8.086

6.  Should lung transplantation be performed using donation after cardiac death? The United States experience.

Authors:  David P Mason; Lucy Thuita; Joan M Alster; Sudish C Murthy; Marie M Budev; Atul C Mehta; Gösta B Pettersson; Eugene H Blackstone
Journal:  J Thorac Cardiovasc Surg       Date:  2008-10       Impact factor: 5.209

7.  Lung allocation score predicts survival in lung transplantation patients with pulmonary fibrosis.

Authors:  Eric S Weiss; Jeremiah G Allen; Christian A Merlo; John V Conte; Ashish S Shah
Journal:  Ann Thorac Surg       Date:  2009-12       Impact factor: 4.330

8.  Late primary graft dysfunction after lung transplantation and bronchiolitis obliterans syndrome.

Authors:  H J Huang; R D Yusen; B F Meyers; M J Walter; T Mohanakumar; G A Patterson; E P Trulock; R R Hachem
Journal:  Am J Transplant       Date:  2008-09-10       Impact factor: 8.086

9.  Impact of U.S. Lung Allocation Score on survival after lung transplantation.

Authors:  Christian A Merlo; Eric S Weiss; Jonathan B Orens; Marvin C Borja; Marie Diener-West; John V Conte; Ashish S Shah
Journal:  J Heart Lung Transplant       Date:  2009-08       Impact factor: 10.247

10.  Initial experience with lung donation after cardiocirculatory death in Canada.

Authors:  Marcelo Cypel; Masaaki Sato; Erkan Yildirim; Wojtek Karolak; Fengshi Chen; Jonathan Yeung; Carlos Boasquevisque; Victoria Leist; Lianne G Singer; Kazuhiro Yasufuku; Marc Deperrot; Thomas K Waddell; Shaf Keshavjee; Andrew Pierre
Journal:  J Heart Lung Transplant       Date:  2009-06-28       Impact factor: 10.247
View more
  5 in total

1.  c-Jun N-terminal kinase (JNK)-mediated induction of mSin1 expression and mTORC2 activation in mesenchymal cells during fibrosis.

Authors:  Natalie M Walker; Serina M Mazzoni; Ragini Vittal; Diane C Fingar; Vibha N Lama
Journal:  J Biol Chem       Date:  2018-09-14       Impact factor: 5.157

2.  Incidence and Risk Factors of Abdominal Complications After Lung Transplantation.

Authors:  Fabian Grass; Markus Schäfer; Alessandra Cristaudi; Carine Berutto; John-David Aubert; Michel Gonzalez; Nicolas Demartines; Hans-Beat Ris; Paola M Soccal; Thorsten Krueger
Journal:  World J Surg       Date:  2015-09       Impact factor: 3.352

3.  Pleuroparenchymal fibroelastosis: the prevalence of secondary forms in hematopoietic stem cell and lung transplantation recipients.

Authors:  Francesca Mariani; Beatrice Gatti; Alberto Rocca; Francesca Bonifazi; Alberto Cavazza; Stefano Fanti; Sara Tomassetti; Sara Piciucchi; Venerino Poletti; Maurizio Zompatori
Journal:  Diagn Interv Radiol       Date:  2016 Sep-Oct       Impact factor: 2.630

4.  RC-3095, a selective gastrin-releasing peptide receptor antagonist, does not protect the lungs in an experimental model of lung ischemia-reperfusion injury.

Authors:  Vera L Oliveira-Freitas; Leonardo Dalla Giacomassa Rocha Thomaz; Lucas Elias Lise Simoneti; Christiane Malfitano; Kátia De Angelis; Jane Maria Ulbrich; Gilberto Schwartsmann; Cristiano Feijó Andrade
Journal:  Biomed Res Int       Date:  2015-03-29       Impact factor: 3.411

5.  Role of biomarkers in early infectious complications after lung transplantation.

Authors:  Borja Suberviola; Luzdivina Rellan; Jordi Riera; Reyes Iranzo; Ascension Garcia Campos; Juan Carlos Robles; Rosario Vicente; Eduardo Miñambres; Miguel Santibanez
Journal:  PLoS One       Date:  2017-07-13       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.